Literature DB >> 15883616

The genetics of susceptibility to cutaneous melanoma.

Julia A Newton Bishop1, D Timothy Bishop.   

Abstract

The most common genetic determinants of skin cancer are the genes that control skin color so that the genes expressed as black skin are protective. Within the white population variants at the MC1R locus are shown to increase susceptibility, and recent evidence suggests that polymorphisms in the OCA2 gene interact to modify risk. Other as-yet-unidentified pigment genes may also play a role in susceptibility to melanoma. Thus MC1R variants are the most common low-penetrance melanoma-susceptibility genes so far identified. Other putative low-penetrance susceptibility genes have been explored using candidate gene approaches. Good candidates such as the DNA repair gene XRCC3 and polymorphisms of EGF have been studied but excluded. Other candidates such as BRAF polymorphisms and variants at the CDKN2A locus remain to be fully investigated. More progress has been made in identifying high-penetrance genes, however. The most common (and probably the most penetrant) susceptibility locus is the CDKN2A locus coding for two tumor suppressor proteins, p16 and p14ARF. Mutations at this locus that impact p16, p14ARF or both proteins all increase susceptibility to melanoma. Families inheriting such mutants are at increased risk of cutaneous melanoma, and the penetrance is increased by residence in sunny climates and co-inheritance of MC1R variants. Some families also appear to be at increased risk of pancreatic cancer, but the determinants of susceptibility to pancreatic cancer are not yet understood. Very rare families have germline mutations in the CDK4 gene which impact on the p16 binding site. There are other high-penetrance susceptibility genes, however, which remain undiscovered. There is evidence of one at 1p22. The Melanoma Genetics Consortium (www.genomel.org) continues to explore this and the genetic epidemiology of the CDKN2A locus. Copyright (c) 2005 Prous Science. All rights reserved.

Entities:  

Mesh:

Year:  2005        PMID: 15883616     DOI: 10.1358/dot.2005.41.3.892524

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  8 in total

Review 1.  Familial risk of melanoma and links with other cancers.

Authors:  Kachiu C Lee; H William Higgins; Abrar A Qureshi
Journal:  Melanoma Manag       Date:  2015-02-25

2.  Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi.

Authors:  Berta L Sánchez-Laorden; Cecilia Herraiz; Julio C Valencia; Vincent J Hearing; Celia Jiménez-Cervantes; José C García-Borrón
Journal:  J Cell Physiol       Date:  2009-09       Impact factor: 6.384

3.  Melanoma risk factors, perceived threat and intentional tanning: an international online survey.

Authors:  Richard Bränström; Yu-Mei Chang; Nadine Kasparian; Paul Affleck; Aad Tibben; Lisa G Aspinwall; Esther Azizi; Orna Baron-Epel; Linda Battistuzzi; William Bruno; May Chan; Francisco Cuellar; Tadeusz Debniak; Dace Pjanova; Sławomir Ertmański; Adina Figl; Melinda Gonzalez; Nicholas K Hayward; Marko Hocevar; Peter A Kanetsky; Samantha L Leaf; Frans A van Nieuwpoort; Olita Heisele; Jane Palmer; Barbara Peric; Susana Puig; Althea D Ruffin; Dirk Schadendorf; Nelleke A Gruis; Yvonne Brandberg; Julia Newton-Bishop
Journal:  Eur J Cancer Prev       Date:  2010-05       Impact factor: 2.497

4.  A critical review of Vitamin D and Cancer: A report of the IARC Working Group.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-01

5.  rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility.

Authors:  Maria Peña-Chilet; Maider Ibarrola-Villava; Manuel Martin-González; Marta Feito; Cristina Gomez-Fernandez; Dolores Planelles; Gregorio Carretero; Ana Lluch; Eduardo Nagore; Gloria Ribas
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

6.  A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene.

Authors:  Maider Ibarrola-Villava; Lara P Fernandez; Santos Alonso; M Dolores Boyano; Maria Peña-Chilet; Guillermo Pita; Jose A Aviles; Matias Mayor; Cristina Gomez-Fernandez; Beatriz Casado; Manuel Martin-Gonzalez; Neskuts Izagirre; Concepcion De la Rua; Aintzane Asumendi; Gorka Perez-Yarza; Yoana Arroyo-Berdugo; Enrique Boldo; Rafael Lozoya; Arantxa Torrijos-Aguilar; Ana Pitarch; Gerard Pitarch; Jose M Sanchez-Motilla; Francisca Valcuende-Cavero; Gloria Tomas-Cabedo; Gemma Perez-Pastor; Jose L Diaz-Perez; Jesus Gardeazabal; Iñigo Martinez de Lizarduy; Ana Sanchez-Diez; Carlos Valdes; Angel Pizarro; Mariano Casado; Gregorio Carretero; Rafael Botella-Estrada; Eduardo Nagore; Pablo Lazaro; Ana Lluch; Javier Benitez; Conrado Martinez-Cadenas; Gloria Ribas
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

7.  Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study.

Authors:  Sally Jane O'Shea; Zoe Rogers; Fiona Warburton; Amanda J Ramirez; Julia A Newton-Bishop; Lindsay J L Forbes
Journal:  BMC Cancer       Date:  2017-01-03       Impact factor: 4.430

Review 8.  An Insight into GPCR and G-Proteins as Cancer Drivers.

Authors:  Preeti Kumari Chaudhary; Soochong Kim
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.